Mycoplasma pneumoniae

  • Hjordis M. Foy

Abstract

Mycoplasmas are small pliable pleomorph bacteria lacking cell walls, which have been known in veterinary medicine since 1898. They were first called pleuropneumonialike organisms (PPLOs) for the disease they cause in cattle. (22) Their role as human parasites was recognized in the 1950s. (21,143) They belong to the order Mycoplasmatales, family Mycoplasmataceae, and class Mollicutes. Mycoplasma pneumoniae is best known as a cause of pneumonitis and of a wide spectrum of milder respiratory symptoms, such as bronchitis, bronchiolitis, and pharyngitis. Because the pneumonia is usually mild and leads to full recovery even without antibiotic treatment, it is frequently called “walking pneumonia.” It is often associated with a rise in cold-agglutinin titers . The infection may cause a wide array of complications.

Keywords

Mycoplasma Pneumoniae Acute Respiratory Disease Chest Film Mycoplasma Infection Cold Agglutinin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abramovitz, P., Schvartzman, P., Harel, D., Lis I., and Naot, Y., Direct invasion of the central nervous system by Mycoplasma pneumoniae: A report of two cases, J. Infect. Dis. 155:482–487 (1987).PubMedCrossRefGoogle Scholar
  2. 2.
    Almagor, M., Yatziv, S., and Kahane, I., Inhibition of host cell catalase by Mycoplasma pneumoniae: A possible mechanism for cell injury, Infect. Immun. 41:251–256 (1983).PubMedGoogle Scholar
  3. 3.
    Andrews, C. E., Hopewell, P., Burrell, R. E., Olson, N. O., and Chick, E. W., An epidemic of respiratory infection due to Mycoplasma pneumoniae in a civilian population, Am. Rev. Respir. Dis. 95:972–979 (1967).PubMedGoogle Scholar
  4. 4.
    Arnold, K., Kilbridge, T. M., Miller,W. C., Jr., Smith, T. J., and Cutting, R. T., Mycoplasma pneumonia: A study on hospitalized American patients with pneumonia in Vietnam, Am. J. Trop. Med. Hyg. 26:743–747 (1977).PubMedGoogle Scholar
  5. 5.
    Assaad, F., Gispen, R., Kleemola, M., Syrucek, L., and Esteves, K., Neurological diseases associated with viral and Mycoplasma pneumoniae infections, Bull. Who 58:297–311 (1980).PubMedGoogle Scholar
  6. 6.
    Baernstein, H. D., Jr., Trevisani, E., Axtell, S., and Quilligan, J. J. Jr.,Mycoplasma pneumoniae (Eaton atypical pneumonia agent) in children’s respiratory infections, J. Pediatr. 66:829–837 (1965).PubMedCrossRefGoogle Scholar
  7. 7.
    Balassanian, N., and Robbins, F. C., Mycoplasma pneumoniae infection in families, N. Engl. J. Med. 277:719–725 (1967).PubMedCrossRefGoogle Scholar
  8. 8.
    Berntsson, E., Lagergård, T., Strannegård, O., and Trollfors, B., Etiology of community-acquired pneumonia in out-patients, Eur. J. Clin. Microbiol. 5:446–447 (1986).PubMedCrossRefGoogle Scholar
  9. 9.
    Biberfeld, G., Distribution of antibodies within 19 S and 7 S immunoglobulins following infection with Mycoplasma pneumoniae, J. Immunol. 100:338–347 (1968).PubMedGoogle Scholar
  10. 10.
    Biberfeld, G., Cell-mediated immune response following Mycoplasma pneumoniae infection in man. II. Leukocyte migration inhibition, Clin. Exp. Immunol. 17:43–49 (1974).PubMedGoogle Scholar
  11. 11.
    Biberfeld, G., and Gronowicz, E., Mycoplasma pneumoniae is a polyclonal B-cell activator, Nature 261:238–239 (1976).PubMedCrossRefGoogle Scholar
  12. 12.
    Biberfeld, G., and Norberg, R., Circulating immune complexes in Mycoplasma pneumoniae infection, J. Immunol. 112:413–415 (1974).PubMedGoogle Scholar
  13. 13.
    Biberfeld, G., and Sterner, G., A study of Mycoplasma pneumoniae infections in families, Scand. J. Infect. Dis. 1:39–46 (1969).PubMedGoogle Scholar
  14. 14.
    Biberfeld, G., and Sterner, G., Antibodies in bronchial secretions following natural infection with Mycoplasma pneumoniae, Acta Pathol. Microbiol. Scand. Sect. B 79:599–605 (1971).Google Scholar
  15. 15.
    Biberfeld, G., and Sterner, G., Tuberculin anergy in patients with Mycoplasma pneumoniae infection, Scand. J. Infect. Dis. 8:71–73 (1976).PubMedGoogle Scholar
  16. 16.
    Biberfeld, G., and Sterner, G., Smooth muscle antibodies in Mycoplasma pneumoniae infection, Clin. Exp. Immunol. 24:287–291 (1976).PubMedGoogle Scholar
  17. 17.
    Biberfeld, G., Biberfeld, P., and Sterner, G., Cellmediated immune response following Mycoplasma pneumoniae infection in man, Clin. Exp. Immunol. 41:29–41 (1974).Google Scholar
  18. 18.
    Broome, C. V., La Venture, M., Kaye, H. S., Davis, A. T., White, H., Plikaytis, B. D., and Fraser, D. W., An explosive outbreak of Mycoplasma pneumoniae infection in a summercamp Pediatrics 66:884–888 (1980).PubMedGoogle Scholar
  19. 19.
    Brunner, Z. H., and Chanock, R. M., A radioimmùnoprecipitation test for detection of Mycoplasma pneumoniae antibody (37261), Proc. Soc. Exp. Biol. Med. 143:97–105 (1973).PubMedGoogle Scholar
  20. 20.
    Brunner, H., Greenberg, H. B., James, W. D., Horswood,R. L., Couch, R. B., and Chanock, R. M., Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect. Immun. 8:612–620 (1973).PubMedGoogle Scholar
  21. 21.
    Chanock, R. M., Cook, M. K., Fox, H. H., Parrot, R. H., and Huebner, R. J., Serologic evidence of infection with Eaton agent in lower respiratory illness in childhood. N. Engl. J. Med. 262:648–654 (1960).PubMedCrossRefGoogle Scholar
  22. 22.
    Chanock, R. M., Hayflick, L., and Barile, M. F., Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a Pplo, Proc. Natl. Acad. Sci. USA 48:41–49 (1962).PubMedCrossRefGoogle Scholar
  23. 23.
    Chanock, R. M., Fox, H. H., James, W. D., Gutekunst, R. R., White, R. J., and Senterfit, L. B., Epidemiology of M. pneumoniae infection in military recruits, Ann. N.Y. Acad. Sci. 143:484–496 (1967).PubMedCrossRefGoogle Scholar
  24. 24.
    Cherry, J. D., Hurwitz, S., and Welliver, R.C., Mycoplasma pneumoniae infections and exanthems, J. Pediatr. 87:369–373 (1975).PubMedCrossRefGoogle Scholar
  25. 25.
    Cimolai, N., Schryvers, A., Bryan, L. E., and Woods, D. E., Culture-amplified immunological detection of Mycoplasma pneumoniae in clinical specimens, Diagn. Microbiol. Infect, Dis. 9:207–212 (1988).CrossRefGoogle Scholar
  26. 26.
    Clyde, W. A., Jr., Immunopathology of experimental Mycoplasma pneumoniae disease, Infect. Immun. 4:757–763 (1971).PubMedGoogle Scholar
  27. 27.
    Clyde, W. A., Jr., and Hu, P. C., Antigenic determinants of the attachment protein of Mycoplasma pneumoniae shared by other pathogenic Mycoplasma species, Infect. Immun. 51:690–692 (1986).PubMedGoogle Scholar
  28. 28.
    Colier, A. M., and Clyde, W. A., Appearance of Mycoplasma pneumoniae in lungs of experimentally infected hamsters and sputum from patients with natural disease, Am. Rev. Respir. Dis. 110:765–773 (1974).Google Scholar
  29. 29.
    Commission on Acute Respiratory Diseases, Transmission of primary atypical pneumonia to human volunteers, J. Am. Med. Assoc. 127:146–149 (1945).CrossRefGoogle Scholar
  30. 30.
    Cooney, M. K., Fox, J. P., and Hall, C. E., The Seattle virus watch. Vi. Observations of infections with and illness due to parainfluenza, mumps and respiratory syncytial viruses and Mycoplasma pneumoniae, Am. J. Epidemiol. 101:532–551 (1975).PubMedGoogle Scholar
  31. 31.
    Copps, C. J., Allen, V. D., Sueltmann, S., and Evans, A. S., A community outbreak of Mycoplasma pneumonia, J. Am. Med. Assoc. 204:123–128 (1968).CrossRefGoogle Scholar
  32. 32.
    Cordero, L., Cuadrado, R., Hall, C. B., and Horstmann, D. M., Primary atypical pneumonia: An epidemic caused by Mycoplasma pneumoniae, J. Pediatr. 71:112 (1967).Google Scholar
  33. 33.
    Costea, N., Yakulis, V. J., and Heller, P., The mechanism of induction of cold agglutinins by Mycoplasma pneumoniae, J. Immunol. 106:598–604 (1971).PubMedGoogle Scholar
  34. 34.
    Couch, R. B., Cate, T. R., and Chanock, R. M., Infection with artificially propagated Eaton agent, J. Am. Med. Assoc. 187:442–447 (1964).CrossRefGoogle Scholar
  35. 35.
    Davies, B. H., Edwards, J. H., and Seaton, A., Cross reacting antibodies to Micropolyspora faeni in Mycoplasma pneumoniae infection, Clin. Allergy 5:217–224 (1975).PubMedCrossRefGoogle Scholar
  36. 36.
    Davis, C. P., Cochran, S., Lisse, J., Buck, G., Dinuzzo, A. R., Weber, T., and Reinarz, J. A., Isolation of Mycoplasma pneumoniae from synovial fluid samples in a patient with pneumonia and polyarthritis, Arch. Intern. Med. 148:969–970 (1988).PubMedCrossRefGoogle Scholar
  37. 37.
    Denny, F. W., Clyde, W. A., Jr., and Glezen,W. P., Mycoplasma pneumoniae disease: Clinical spectrum, pathophysiology, epidemiology, and control, J. Infect. Dis. 123:74–92 (1971).PubMedCrossRefGoogle Scholar
  38. 38.
    De Vos, M., Van Nimmen, L. V., and Baele, G., Disseminated intravascular coagulation during a fatal Mycoplasma pneumoniae infection, Acta Haematol. 52:120–125 (1974).PubMedCrossRefGoogle Scholar
  39. 39.
    Dowdle, W. R., Stewart, J. A., Heyward, J. T., and Robinson, R. Q., Mycoplasma pneumoniae infections in a children’s population: A five-year study, Am. J. Epidemiol. 85:137–146 (1967).PubMedGoogle Scholar
  40. 40.
    Eaton, M. D., Meikeljohn, G., and Van Herick, W., Studies on the etiology of primary atypical pneumonia: A filterable agent transmissible to cotton rats, hamsters, and chick embryos, J. Exp. Med. 79:649–668 (1944).PubMedCrossRefGoogle Scholar
  41. 41.
    Edwards,E. A., Crawford, Y. E., Pierce, W. E., and Peckinpaugh, R. O., A longitudinal study of Mycoplasma pneumoniae infections in Navy recruits by isolation and seroepidemiology, Am. J. Epidemiol. 104:556–562 (1976).PubMedGoogle Scholar
  42. 42.
    Evans, A. S., Serologic studies of acute respiratory infections in military personnel, Yale J. Biol. Med. 48:201–209 (1975).PubMedGoogle Scholar
  43. 43.
    Evans, A. S., and Brobst, M., Bronchitis, pneumonitis and pneumonia in University of Wisconsin students, N. Engl. J. Med. 265:401–405 (1961).PubMedCrossRefGoogle Scholar
  44. 44.
    Evans, A. S., Allen, V., and Sueltmann, S., Mycoplasma pneumoniae infections in University of Wisconsin students, Am. Rep. Respir. Dis. 96:237–244 (1967).Google Scholar
  45. 45.
    Evatt, B. L., Dowdle, W. R., Johnson, M., Jr., and Heath, C. W., Epidemic Mycoplasma pneumonia, N. Engl. J. Med. 285:374–378 (1971).PubMedCrossRefGoogle Scholar
  46. 46.
    Fernald, G. W., Immunologic aspects of experimental Mycoplasma pneumoniae infection, J. Infect. Dis. 119:255–266 (1969).PubMedCrossRefGoogle Scholar
  47. 47.
    Fernald, G. W., In vitro response of human lymphocytes to Mycoplasma pneumoniae, Infect. Immun. 5:552–558 (1972).PubMedGoogle Scholar
  48. 48.
    Fernald, G. W., and Clyde, W. A., Jr., Protective effect of vaccines in experimental Mycoplasma pneumoniae disease, Infect. Immun. 1:559–565 (1970).PubMedGoogle Scholar
  49. 49.
    Fernald, G. W., Clyde, W. A., Jr., and Bienenstock, J., Immunoglobulin-containing cells in lungs of hamsters infected with Mycoplasma pneumoniae, J. Immunol. 108: 1400–1408 (1972).PubMedGoogle Scholar
  50. 50.
    Fernald, G. W., Collier, A. M., and Clyde, W. A., Respiratory infections due to Mycoplasma pneumoniae in infants and children, Pediatrics 55:327–334 (1975).PubMedGoogle Scholar
  51. 51.
    Fleischhauer, P., Huben, U., Mertens, H., Sethi, K. K., and Thurmann, D., Nachweis von Mycoplasma pneumoniae im Liquor bei akuter Polyneuritis, Dtsch. Med. Wochenschr. 97:678–682 (1972).PubMedCrossRefGoogle Scholar
  52. 52.
    Foy, H. M., Pneumonia: Mycoplasma pneumoniae, in: Communicable and Infectious Diseases, 8th ed. (F. H. Top, Sr., and P. F. Wehrle, eds.), pp. 535–549, Mosby, St. Louis, 1976.Google Scholar
  53. 53.
    Foy, H. M., Grayston, J. T., Kenny, G. E., Alexander, E. R., and Mcmahan, R., Epidemiology of Mycoplasma pneumoniae infection in families, J. Am. Med. Assoc. 197:859–866 (1966).CrossRefGoogle Scholar
  54. 54.
    Foy, H. M., Kenny, G. E., Mcmahan, R., Mansy, A. M., and Grayston, J. T., Mycoplasma pneumoniae pneumonia in an urban area, J. Am. Med. Assoc. 30:1666–1672 (1970).CrossRefGoogle Scholar
  55. 55.
    Foy, H. M., Kenny, G. E., McMahan, R., Kaiser, G., and Grayston, J. T., Mycoplasma pneumoniae in the community, Am. J. Epidemiol. 93:55–67 (1971).PubMedGoogle Scholar
  56. 56.
    Foy, H. M., Ochs, H., Davis, S. D., Kenny, G. E., and Luce, R. R., Mycoplasma pneumoniae infections in patients with immunodeficiency syndromes: Report of four cases, J. Infect. Dis. 127:388–393 (1973).PubMedCrossRefGoogle Scholar
  57. 57.
    Foy, H. M., Cooney, M. K., Mcmahan, R., and Grayston, J. T., Viral and mycoplasmal pneumonia in a prepaid medical care group during an eight-year period, Am. J. Epidemiol. 97:93–102 (1973).PubMedGoogle Scholar
  58. 58.
    Foy, H. M., Kenny, G. E., Sefi, R., Ochs, H. D., and Allan, I. D., Second attacks of pneumonia due to Mycoplasma pneumoniae, J. Infect. Dis. 135:673–677 (1977).PubMedCrossRefGoogle Scholar
  59. 59.
    Foy, H. M., Kenny, G. E., Cooney, M. K., and Allan, I. D., Long-term epidemiology of infections with Mycoplasma pneumoniae, J. Infect. Dis. 139:681–687 (1979).PubMedCrossRefGoogle Scholar
  60. 60.
    Foy, H. M., Kenny, G. E., Cooney, M. K., Allan, I. D., and Van Belle, G., Naturally acquired immunity to pneumonia due to Mycoplasma pneumoniae, J. Infect. Dis. 147:967–973 (1983).PubMedCrossRefGoogle Scholar
  61. 61.
    Foy, H. M., Nolan, C. M., and Allan, I. D., Epidemiologic aspects of M. pneumoniae disease complications: A review, Yale J. Biol. Med. 56:469–473 (1983).PubMedGoogle Scholar
  62. 62.
    Freeman, R., King, B., and Hambling,M. H., Infection with Mycoplasma pneumoniae after open-heart surgery, J. Thorac. Cardiovasc. Surg. 66:642–644 (1973).PubMedGoogle Scholar
  63. 63.
    Ganick, D. J., Wolfson, J., Gilbert, E. F., and Joo, P., Mycoplasma infection in the immunosuppressed leukemic patient, Arch. Pathol. Lab. Med. 104:535–536 (1980).PubMedGoogle Scholar
  64. 64.
    Glezen, W. P., Clyde, W. A., Jr., Senior, R. J., Sheaffer, C. I., and Denny,F. W., Group A streptococci, mycoplasmas, and viruses associated with acute pharyngitis, J. Am. Med. Assoc. 202:455–460 (1967).CrossRefGoogle Scholar
  65. 65.
    Glezen, W. P., Thornburg, G., Chin, T. D. Y., and Wenner, H. A., Significance of Mycoplasma infections in children with respiratory disease, Pediatrics 39:516–525 (1967).PubMedGoogle Scholar
  66. 66.
    Govil, M. K., Agrawal, B. D., Lal, M. M., Nath, K., Sharma, B. K., Samuel, K. C., and Gupta, B. K., A study of acute respiratory diseases with special references to Mycoplasma pneumoniae infections, J. Assoc. Physicians India 23:272–303 (1975).Google Scholar
  67. 67.
    Grayston, J. T., Foy, H. M., and Kenny, G. E., The epidemiology of Mycoplasma infections of the human respiratory tract, in: The Mycoplasmatales and the L-Phase of Bacteria (L. Hayflick, ed.), pp. 651–682, Appleton-Century-Crofts, New York, 1969.Google Scholar
  68. 68.
    Greenberg, H., Helms, C. M., Brunner, H., and Chanock, R. M., Asymptomatic infection of adult volunteers with a temperature sensitive mutant of Mycoplasma pneumoniae, Proc. Natl. Acad. Sci. USA 71:4015–4019 (1974).PubMedCrossRefGoogle Scholar
  69. 69.
    Hanukoglu, A., Hebroni, S., and Fried, D., Pulmonary involvement in Mycoplasma pneumoniae infection in families, Infection 14:1–6 (1986).PubMedCrossRefGoogle Scholar
  70. 70.
    Harris, R., Marmion, B. P., Varkanis, G., Kok, T., Lunn, B., and Martin, J., Laboratory diagnosis of Mycoplasma pneumoniae infection. 2. Comparison of methods for the direct detection of specific antigen or nucleic acid sequences in respiratory exudates, Epidemiol. Infect. 101:685–694 (1988).PubMedCrossRefGoogle Scholar
  71. 71.
    Hatch, M. T., Wright, D. N., and Bailey, G. D., Response of airborne Mycoplasma pneumoniae to abrupt changes in relative humidity, Appl. Microbiol. 19:232–238 (1970).PubMedGoogle Scholar
  72. 72.
    Hernandez, L. A., Urquhart, G. E. D., and Dick, W.C., Mycoplasma pneumoniae infection and arthritis in man, Br. Med. J. 2:14–16 (1977).PubMedCrossRefGoogle Scholar
  73. 73.
    Hodges, G. R., Fass, R. J., and Saslaw, S., Central nervous system disease associated with Mycoplasma pneumoniae infection, Arch. Intern. Med. 130:277–282 (1972).PubMedCrossRefGoogle Scholar
  74. 74.
    Hu, P. C., Powell, D. A., Albright, F., Gardner, D. E., Collier, A. M., and Clyde, W. A., Jr., A solid-phase radioimmunoassay for detection of antibodies against Mycoplasma pneumoniae, J. Clin. Lab. Immunol. 11:209–213 (1983).PubMedGoogle Scholar
  75. 75.
    Hu, P. C., Huang, C.-H., Huang, Y.-S., Collier, A. M., and Clyde, W. A., Jr., Demonstration of multiple antigenic determinants on Mycoplasma pneumoniae attachment protein by monoclonal antibodies, Infect. Immun. 50:292–296 (1985).PubMedGoogle Scholar
  76. 76.
    Jacobs, E., Bennewitz, A., and Bredt, W., Reaction pattern of human anti Mycoplasma pneumoniae antibodies in enzyme-linked immunosorbent assays and immunoblotting, J. Clin. Microbiol. 23:517–522 (1986).PubMedGoogle Scholar
  77. 77.
    Janney, F. A., Lee, L. T., and Howe, C., Cold hemagglutinin cross-reactivity with Mycoplasma pneumoniae, Infect. Immun. 22:29–33 (1978).PubMedGoogle Scholar
  78. 78.
    Jansson, E., Von Essen, R., and Tuuri, S., Mycoplasma pneumoniae pneumonia in Helsinki 1962–1970, Scand. J. Infect. Dis. 3:51–54 (1971).PubMedGoogle Scholar
  79. 79.
    Jarstrand, C., Camner, P., and Philipson, K., Mycoplasma pneumoniae and tracheobronchial clearance, Am. Rev. Respir. Dis. 110:415–419 (1974).PubMedGoogle Scholar
  80. 80.
    Jemski, J. V., Hetsko, C. M., Helms, C. M., Grizzard, M. B., Walker, J. S., and Chanock, R. M., Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: Effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters, Infect. Immun. 16:93–98 (1977).PubMedGoogle Scholar
  81. 81.
    Jensen, K. J., Senterfit, L. B., Scully, W. E., Conway, T. J., West, R. F., and Drummy, W. W., Mycoplasma pneumoniae infections in children: An epidemiologic appraisal in families treated with oxytetracycline, Am. J. Epidemiol. 86:419–432 (1967).PubMedGoogle Scholar
  82. 82.
    Kasahara, I., Otsubo, Y., Yanase, T., Oshima, H., Ichimaru, H., and Nakamura, M., Isolation and characterization of Mycoplasma pneumoniae from cerebrospinal fluid of a patient with pneumonia and meningoencephalitis, J. Infect. Dis. 152:823–825 (1985).PubMedCrossRefGoogle Scholar
  83. 83.
    Kenny, G. E., Mycoplasmas, in: Manual of Clinical Microbiology (E. H. Lennette, A. Balows, W. J. Hausler, Jr., and H. J. Shadomy, eds.) pp. 407–411, American Society for Microbiology, Washington, D.C., 1985.Google Scholar
  84. 84.
    Kenny, G. E., Serology of mycoplasmal infections, in: Manual of Clinical Immunology (N. R. Rose, H. Friedman, and J. L. Fahey, eds.), pp. 440–445, American Society for Microbiology, Washington, D.C., 1986.Google Scholar
  85. 85.
    Kingston, J. R., Chanock, R. M., Mufson, M. S., Hellman, L. P., James, W. D., Fox, H. H., Manko, M. A., and Boyers, J., Eaton agent pneumonia, J. Am. Med. Assoc. 176:118–123 (1961).CrossRefGoogle Scholar
  86. 86.
    Kleemola, M., and Käyhty, H., Increase in titers of antibodies to Mycoplasma pneumoniae in patients with purulent meningitis, J. Infect. Dis. 146:284–288 (1982).PubMedCrossRefGoogle Scholar
  87. 87.
    Koletsky, R. J., and Weinstein, A. J., Fulminant Mycoplasma pneumoniae infection. Report of a fatal case, and a review of the literature, Am. Rev. Respir. Dis. 122:491–496 (1980).PubMedGoogle Scholar
  88. 88.
    Komaroff, A. L., Aronson, M. D., Pass, T. M., Ervin, C. T., Branch, W. T., Jr., and Schachter, J., Serological evidence of chlamydial and mycoplasmal pharyngitis in adults, Science 222:927–929 (1983).PubMedCrossRefGoogle Scholar
  89. 89.
    Krause, D. C., and Baseman, J. B., Inhibition of Mycoplasma pneumoniae hemadsorption and adherence to respiratory epithelium of antibodies to a membrane protein, Infect. Immun. 39:1180–1186 (1983).PubMedGoogle Scholar
  90. 90.
    Krause, D. C., Leith, D. K., Wilson, R. M., and Baseman, J. B., Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence, Infect. Immun. 35:809–817 (1982).PubMedGoogle Scholar
  91. 91.
    Leibowitz, Z., Schvartzman, P., Epstein, L., Lis, I., and Naot, Y., An outbreak of Mycoplasma pneumoniae pneumonia in two kibbutzim: A clinical and epidemiologic study, Isr. J. Med. Sci. 24:88–92 (1988).PubMedGoogle Scholar
  92. 92.
    Leinikki, P. O., Panzar, P., and Tykka, H., Immunoglobulin M antibody response against Mycoplasma pneumoniae lipid antigen in patients with acute pancreatitis, J. Clin. Microbiol. 8:113–118 (1978).PubMedGoogle Scholar
  93. 93.
    Lerer, R. J., and Kalavsky, S. M., Central nervous system disease associated with Mycoplasma pneumoniae infection: Report of five cases and review of the literature, Pediatrics 52:658–668 (1973).PubMedGoogle Scholar
  94. 94.
    Levine, D. P., and Lerner, A. M., The clinical spectrum of Mycoplasma pneumoniae infections, Med. Clin. North Am. 62:961–978 (1978).PubMedGoogle Scholar
  95. 95.
    Lind, K., and Bentzon, M. W., Epidemics of Mycoplasma pneumoniae infection in Denmark from 1958 to 1974, Int. J. Epidemiol. 5:267–277 (1976).PubMedCrossRefGoogle Scholar
  96. 96.
    Lind, K., and Bentzon, M. W., Changes in the epidemiological pattern of Mycoplasma pneumoniae infections in Denmark, Epidemiol. Infect. 101:377–386 (1988).PubMedCrossRefGoogle Scholar
  97. 97.
    Lind, K., Lindhardt, B. O., Schütten, H. J., Bloom, J., and Christiansen, C., Serological cross-reactions between Mycoplasma genitalium and Mycoplasma pneumoniae, J. Clin. Microbiol. 20:1036–1043 (1984).PubMedGoogle Scholar
  98. 98.
    Liu, C., Studies on primary atypical pneumonia. I. Localization, isolation, and cultivation of virus in chick embryos, J. Exp. Med. 106:455–456 (1957).PubMedCrossRefGoogle Scholar
  99. 99.
    Liu, C., Eaton, M. D., and Heyl, J. T., Studies on primary atypical pneumonia. II. Observations concerning the development and immunological characteristics of antibody in patients, J. Exp. Med. 109:545–556 (1959).PubMedCrossRefGoogle Scholar
  100. 100.
    Loomes, L. M., Uemura, K., Childs, R. A., Paulson, J. C., Rogers, G. N., Scudder, P. R., Michalski, J.-C., Hounsell,E. F., Taylor-Robinson, D., and Feizi, T., Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen type, Nature 307:560–563 (1984).PubMedCrossRefGoogle Scholar
  101. 101.
    Lyell, A., Gordon, A. M., Dick, H. M., and Sommerville, R. G., Mycoplasmas and erythema multiforme, Lancet 2:1116–1118 (1967).PubMedCrossRefGoogle Scholar
  102. 102.
    Maida, E., Immunological reactions against Mycoplasma pneumoniae in multiple sclerosis: Preliminary findings, J. Neurol. 229:103–111 (1983).PubMedCrossRefGoogle Scholar
  103. 103.
    Maisel, J. C., Babbitt, L. H., and John, T. J., Fatal Mycoplasma pneumoniae infection with isolation of organisms from lung, J. Am. Med. Assoc. 202:287–290 (1967).CrossRefGoogle Scholar
  104. 104.
    Maisel, J. C., Pierce, W. E., and Stille, W. T., Chemoprophylaxis, Am. Rev. Respir. Dis. 97:366–375 (1967).Google Scholar
  105. 105.
    Marmion, B. P., and Goodburn, G. M., Effect of an organic gold salt on Eaton’s primary atypical pneumonia agent and other observations, Nature 189:247–248 (1961).PubMedCrossRefGoogle Scholar
  106. 106.
    Mccormick, D. P., and Wenzel, R. P., Senterfit, L. B., and Beam, W. E., Jr., Relationship of pre-existing antibody to subsequent infection by Mycoplasma pneumoniae in adults, Infect. Immun. 9:53–59 (1974).PubMedGoogle Scholar
  107. 107.
    Mcgavin, C., Farmer’s lung after Mycoplasma pneumoniae infection, Thorax 41:68–69 (1986).PubMedCrossRefGoogle Scholar
  108. 108.
    Mcmillan, J. A., Sandstrom, C., Weiner, L. B., Forbes, B. A., Woods,M., Howard, T., Poe, L., Keller, K., Corwin, R. M., and Winkelman, J. W., Viral and bacterial organisms associated with acute pharyngitis in a school-aged population, J. Pediatr. 109:747–752 (1986).PubMedCrossRefGoogle Scholar
  109. 109.
    Meyers, B. R., and Hirschman, S. Z., Fatal infections associated with Mycoplasma pneumoniae: Discussion of three cases with necropsy findings, Mt. Sinai J. Med. 39:258–264 (1972).PubMedGoogle Scholar
  110. 110.
    Michel, D., Laurent, B., Granouillet, R., and Gaudin-Terrasse, O. D., Infections aiguës, récentes, et parfois persistantes à Mycoplasma pneumoniae, associées à des manifestations neurologiques, Rev. Neurol. 137:393–413 (1981).PubMedGoogle Scholar
  111. 111.
    Mizutani, H., and Mizutani, H., The skin-reactive antigens of Mycoplasma pneumoniae, Jpn. J. Microbiol. 19:157–162 (1975).PubMedGoogle Scholar
  112. 112.
    Mizutani, H., and Mizutani, H., Immunologic responses in patients with Mycoplasma pneumoniae infections, Am. Rev. Respir. Dis. 127:175–179 (1983).PubMedGoogle Scholar
  113. 113.
    Mizutani, H., and Mizutani, H., Circulating immune complexes in patients with mycoplasmal pneumonia, Am. Rev. Respir. Dis. 130:627–629 (1984).PubMedGoogle Scholar
  114. 114.
    Mogabgab, W.J. Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959–1966, Am. Rev. Respir. Dis. 97:345–358 (1968).PubMedGoogle Scholar
  115. 115.
    Mogabgab, W. J., Protective efficacy of killed Mycoplasma pneumoniae vaccine measured in large-scale studies in a military population, Am. Rev. Respir. Dis. 108:899–908 (1973).PubMedGoogle Scholar
  116. 116.
    Monto, A. S., Bryan, E. R., and Rhodes, L. M., The Tecumseh study of respiratory illness. VII. Further observations on the occurrence of respiratory syncytial virus and Mycoplasma pneumoniae infections, Am. J. Epidermiol. 100:458–468 (1974).Google Scholar
  117. 117.
    Murray, H. W., Masur, H., Senterfit, L. B., and Roberts, R. B., The protean manifestations of Mycoplasma pneumoniae infection in adults, Am. J. Med. 58:229–242 (1975).PubMedCrossRefGoogle Scholar
  118. 118.
    Naftalin, J. M., Wellisch, G., Kahana, Z., and Deingott, D., Mycoplasma pneumoniae septicemia, J. Am. Med. Assoc. 228:565 (1974).CrossRefGoogle Scholar
  119. 119.
    Nagayama, Y., Sakurai, N., Yamamoto, K., Honda, A., Makuta, M., and Suzuki, R., Isolation of Mycoplasma pneumoniae from children with lower-respiratory-tract infections, J. Infect. Dis. 157:911–917 (1988).PubMedCrossRefGoogle Scholar
  120. 120.
    Nakamura, S., Ebisawa, I., Kitamoto, O., and Sato, T., Persistence of serum antibody following Mycoplasma pneumoniae infection, Am. Rev. Respir. Dis. 101:620–622 (1970).PubMedGoogle Scholar
  121. 121.
    Nakao, T., and Umetsu, M., An outbreak of Mycoplasma pneumoniae infection in a community, Tohoku J. Exp. Med. 102:23–31 (1970).PubMedCrossRefGoogle Scholar
  122. 122.
    Nakao, T., Orii, T., and Umetsu, M., Mycoplasma pneumoniae pneumonia with pleural effusion, with special reference to isolation of Mycoplasma pneumoniae from pleural fluid, Tohoku J. Exp. Med. 104:13–18 (1971).PubMedCrossRefGoogle Scholar
  123. 123.
    Nakayama, T., Urano, T., Osano, M., Maehara, N., and Makino, S., A interferon in the sera of patients infected with Mycoplasma pneumoniae, J. Infect. Dis. 154:904–906 (1986).PubMedCrossRefGoogle Scholar
  124. 124.
    Naot, Y., Lis, E., Siman-Tov, R., and Brunner, H., Comparison of enzyme-linked immunosorbent assay and radioimmunoprecipitation test for detection of immunoglobulin A antibodies to Mycoplasma pneumoniae in nasal secretions, J. Clin. Microbiol. 24:892–893 (1986).PubMedGoogle Scholar
  125. 125.
    Niitu, Y., Mycoplasma pneumoniae infections, Acta Paediatr. Jpn. 27:73–90 (1984).CrossRefGoogle Scholar
  126. 126.
    Niitu, Y., Hasegawa, S., Suetake, T., Kubota, H., Komatsu, S., and Horikawa, M., Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics. J. Pediatr. 76:438–443 (1970).PubMedCrossRefGoogle Scholar
  127. 127.
    Noah, N.D. Mycoplasma pneumoniae infection in the United Kingdom: An analysis of reports to the public health laboratory service in England and Wales, Infection 4(Suppl. 1):25–28 (1976).PubMedCrossRefGoogle Scholar
  128. 128.
    Noah, N. D., and Urquhart, A. M., Epidemiology of Mycoplasma pneumoniae infection in the British Isles, 19749, J. Infect. 2:191–194 (1980).PubMedCrossRefGoogle Scholar
  129. 129.
    Oldenburger, D., Carson, J. P., Gundlach, W. J., Ghaly, F. I., and Wright, W. H., Legionnaires’ disease: Association with Mycoplasma pneumonia and disseminated intravascular coagulation, J. Am. Med. Assoc. 241:1269–1270 (1979).CrossRefGoogle Scholar
  130. 130.
    Parker, F., Jr., Jolliffe, L. S., and Finland, M., Primary atypical pneumonia: Report of eight cases with autopsies, Arch. Pathol. 44:581–608 (1947).Google Scholar
  131. 131.
    Patscheke, H., Breinl, M., and Schafer, E., Antibody assay for adenoviruses and Mycoplasma pneumoniae by the platelet aggregation test, Z. Immunitaetsforsch. 151:341–349 (1976).Google Scholar
  132. 132.
    Peterson, D. L., Ham, T. H., and Finland, M., Cold agglutinins (autohemagglutinins) in primary atypical pneumonias, Science 97:167 (1943).PubMedCrossRefGoogle Scholar
  133. 133.
    Poncz, M., Kane, E., and Gill, F. M., Acute chest syndrome in sickle cell disease: Etiology and clinical correlates, J. Pediatr. 107:861–866 (1985).PubMedCrossRefGoogle Scholar
  134. 134.
    PönkÄ, A., Occurrence of serologically verified Mycoplasma pneumoniae infections in Finland and in Scandinavia in 1970–1977, Scand. J. Infect. Dis. 12:27–31 (1980).Google Scholar
  135. 135.
    Public Heath Laboratory Service, Report from the Phls Communicable Disease Surveillance Centre, Br. Med. J. 294:361 (1987).CrossRefGoogle Scholar
  136. 136.
    Purcell, R., Chanock, R., and Taylor-Robinson, R., Serology of the Mycoplasmas of man, in: The Mycoplasmatales and the L-Phase of Bacteria (L. Hayflick, ed.), pp. 221–264, Appleton-Century-Crofts, New York, 1969.Google Scholar
  137. 137.
    Putman, C. E., Baumgarten, A., and Gee, J. B. L., The prevalence of mycoplasmal complement-fixing antibodies in sarcoidosis, Am. Rev. Respir. Dis. 3:364–365 (1975).Google Scholar
  138. 138.
    RäisÄNen, S. M., Suni, J., and Leinikki, P., Serological diagnosis of Mycoplasma pneumoniae infection by enzyme immunoassay, J. Clin. Pathol. 33:836–840 (1980).PubMedCrossRefGoogle Scholar
  139. 139.
    Reimann, H. A., An acute infection of the respiratory tract with typical pneumonia: A disease entity probably caused by a filterable virus, J. Am. Med. Assoc. 111:2377–2384 (1938).CrossRefGoogle Scholar
  140. 140.
    Rifkind, D., Chanock, R., Kravetz, H., Johnson, K., and Knight, V., Ear involvement (myringitis) and primary atypical pneumonia following inoculation of volunteers with Eaton agent, Am. Rev. Respir. Dis. 85:479–489 (1962).PubMedGoogle Scholar
  141. 141.
    Roifman, C. M., Rao, C. P., Lederman, H. M., Lavi, S., Quinn, P., and Gelfand, E. W., Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinema, Am. J. Med. 80:590–594 (1986).PubMedCrossRefGoogle Scholar
  142. 142.
    Ruhrmann, G., and Holthusen, W., Mycoplasma infection and erythromycin therapy in childhood, Scott. Med. J. 22:401–403 (1977).PubMedGoogle Scholar
  143. 143.
    Rytel, M. W., Primary atypical pneumonia: Current concepts, Am. J. Med. Sci. 247:118–138 (1964).CrossRefGoogle Scholar
  144. 144.
    Sabato, A. R., Martin, A. J., Marmion, B. P., Kok, T. W., and Cooper, D. M., Mycoplasma pneumoniae: Acute illness, antibiotics, and subsequent pulmonary function, Arch. Dis. Child. 59:1034–1037 (1984).PubMedCrossRefGoogle Scholar
  145. 145.
    Saliba, G. S., Glezen, W. P., and Chin, T. D. Y., Mycoplasma pneumoniae infection in a resident boys’ home, Am. J. Epidemiol. 86:409–418 (1967).Google Scholar
  146. 146.
    Sande, M. A., Gadot, F., and Wenzel, R. P., Point source epidemic of Mycoplasma pneumoniae infection in a prosthodontics laboratory, Am. Rev. Respir. Dis. 112:213–217 (1975).PubMedGoogle Scholar
  147. 147.
    Sawyer, R., and Sommerville, R. G., An outbreak of Mycoplasma pneumoniae infection in a nuclear submarine, J. Am. Med. Assoc. 195:958–959 (1966).CrossRefGoogle Scholar
  148. 148.
    Shames, J. M., George, R. B., Holliday, W. B., Rasch,J. R., and Mogabgab, W. J., Comparison of antibiotics in the treatment of mycoplasmal pneumonia, Arch. Intern. Med. 125:680–684 (1970).PubMedCrossRefGoogle Scholar
  149. 149.
    Shulman, S. T., Bartlett, J., Clyde, W. A., Jr., and Ayoub, E. M., The unusual severity of mycoplasmal pneumonia in children with sickle-cell disease, N. Engl. J. Med. 287:164–167 (1972).PubMedCrossRefGoogle Scholar
  150. 150.
    Smilack, J. D., Burgin, W. W., Jr., Moore, W. L., Jr., and Sanford, J. P., Mycoplasma pneumoniae pneumonia and clindamycin therapy: Failure to demonstrate efficacy, J. Am. Med. Assoc. 228:729–731 (1974).CrossRefGoogle Scholar
  151. 151.
    Smith, C. B., Friedewald, W. T., and Chanock, R. M., Inactivated Mycoplasma pneumoniae vaccine: Evaluation in volunteers, J. Am. Med. Assoc. 199:353–358 (1967).CrossRefGoogle Scholar
  152. 152.
    Sobeslavsky, O., Syrucek, L., Bruckova, M., and Abramovic, M., The etiological role of Mycoplasma pneumoniae in otitis media in children, Pediatrics 35:652–657 (1964).Google Scholar
  153. 153.
    Sobeslavsky, O., Prescott, B., and Chanock, R. M., Adsorption of Mycoplasma pneumoniae to neuraminic acid receptors of various cells and possible role in virulence, J. Bacteriol. 96:695–705 (1968).PubMedGoogle Scholar
  154. 154.
    Steinberg, P., White, R. J., Fuld, S. L., Gutekunst, R. R.,Chanock, R. M., and Senterfit, L. B., Ecology of Mycoplasma pneumoniae infections in Marine recruits at Parris Island, South Carolina, Am. J. Epidemiol. 89:62–73 (1969).PubMedGoogle Scholar
  155. 155.
    Sterner, G., De Hevesy, G., Tunevall, G., and Wolontis, S., Acute respiratory illness with Mycoplasma pneumoniae: An outbreak in a home for children, Acta Paediatr. Scand. 55:280–286 (1966).PubMedCrossRefGoogle Scholar
  156. 156.
    Stevens, D., Swift, P. G. F., Johnston, P. G. B., Kearney, P. J., Corner, B. D., and Burman, D., Mycoplasma pneumoniae infections in children, Arch. Dis. Child. 53:3842 (1978).CrossRefGoogle Scholar
  157. 157.
    Stopler, T., and Branski, D., Resistance of Mycoplasma pneumoniae to macrolides, lincomycin and streptogramin B, J. Antimicrob. Chemother. 18:358–364 (1986).CrossRefGoogle Scholar
  158. 158.
    Stutman, H. R., Stevens-Johnson syndrome and Mycoplasma pneumoniae: Evidence for cutaneous infection, Clin. Lab. Observ. 111:845–847 (1987).Google Scholar
  159. 159.
    Suhs, R. H., and Feldman, H. A., Serologic epidemiologic studies with M. pneumoniae. II. Prevalence of antibodies in several populations, Am. J. Epidemiol. 83:357–365 (1966).PubMedGoogle Scholar
  160. 160.
    Sukonthaman, A., Freeman, J. D., Ratanavararak, M., Khaoparisuthi, V., and Snidvongs, W., Mycoplasma pneumoniae infections-The first demonstration of an outbreak at a Kampuchean holding center in Thailand, J. Med. Assoc. Thailand 64:392–400 (1981).Google Scholar
  161. 161.
    Sussman, S. J., Magoffin, R. L., Lennette, E. H., and Schieble, J., Cold agglutinins, Eaton agent, and respiratory infections of children, Pediatrics 38:571–577 (1966).PubMedGoogle Scholar
  162. 162.
    Szabo, N., Loos, T., and Martha, I., Durch Mycoplasma pneumoniae verursachte Erkrankungen im Kindesalter, Z. Erkr. Atmungsorgane 148:307–311 (1977).PubMedGoogle Scholar
  163. 163.
    Taylor-Robinson, D., Shiral, A., Sobeslavsky, O., and Chanock, R. M., Serologic response to Mycoplasma pneumoniae infection. Ii. Significance of antibody measured by different techniques, Am. J. Epidemiol. 84:301–313 (1966).PubMedGoogle Scholar
  164. 164.
    Taylor-Robinson, D., Sobeslavsky, O., Jensen, K. E., Senterfit, L. B., and Chanock, R. M., Serologic response to Mycoplasma pneumoniae infection. I. Evaluation of immunofluorescence, complement fixation, indirect hemagglutination, and tetrazolium reduction inhibition tests for the diagnosis of infection, Am. J. Epidemiol. 83:287–298 (1966).PubMedGoogle Scholar
  165. 165.
    Taylor-Robinson, D., Gumpel, J. M., Hill, A., and Swannell, A. J., Isolation of Mycoplasma pneumoniae from the synovial fluid of a hypoglobulinaemic patient in a survey of patients with inflammatory polyarthritis, Ann. Rheum. Dis. 51:180–182 (1978).CrossRefGoogle Scholar
  166. 166.
    Taylor-Robinson, D., Webster, A. D. B., Furr, P. M., and Asherson, G. L., Prolonged persistence of Mycoplasma pneumoniae in a patient with hypogammaglobulinaemia, J. Infect. 2:171–175 (1980).PubMedCrossRefGoogle Scholar
  167. 167.
    Tully, J. G., Rose, D. L., Whitcomb,R. F., and Wenzel, R. P., Enhanced isolation of Mycoplasma pneumoniae from throat washings with a newly modified culture medium, J. Infect. Dis. 139:478–482 (1979).CrossRefGoogle Scholar
  168. 168.
    van der Veen, J., and Van Nunen, M. C. J., Role of Mycoplasma pneumoniae in acute respiratory disease in a military population, Am. J. Hyg. 78:293–301 (1963).Google Scholar
  169. 169.
    Vikerfors, T., Brodin, G., Grandien, M., Hirschberg, L., Krook, A., and Pettersson, C., Detection of specific IgM antibodies for the diagnosis of Mycoplasma pneumoniae infections: A clinical evaluation, Scand. J. Infect. Dis. 20:601–610 (1988).PubMedCrossRefGoogle Scholar
  170. 170.
    Vu, A. C., Foy, H. M., Cartwright, F. D., and Kenney, G. E., The principal protein antigens of isolates of Mycoplasm pneumoniae as measured by levels of immunoglobulin G in human serum are stable in strains collected over a 10-year period, Infect. Immun. 55:1830–1836 (1987).PubMedGoogle Scholar
  171. 171.
    Wenzel, R. P., Craven, R. B., Davies, J. A., Hendley, J. O., Hamory, B. H., and Gwaltney, J. M., Jr., Field trial of an inactivated Mycoplasma pneumoniae vaccine. I. Vaccine efficacy, J. Infect. Dis. 134:571–576 (1976).PubMedCrossRefGoogle Scholar
  172. 172.
    Wenzel, R. P., Hendley, J. O., Dodd, W. K., and Gwaltney, J. M., Jr., Comparison of josamycin and erythromycin in the therapy of Mycoplasma pneumoniae pneumonia, Antimicrob. Agents Chemother. 10:899–901 (1976).PubMedCrossRefGoogle Scholar
  173. 173.
    Westerberg, S. C., Smith, C. B., and Renzetti, A. D., Mycoplasma infections in patients with chronic obstructive pulmonary disease, J. Infect. Dis. 127:491–497 (1973).PubMedCrossRefGoogle Scholar
  174. 174.
    Witzleb, V. W., Sprossig, M., Anger, G., and Heidler, S., Erkrankungen des Respirationstraktes durch Mycoplasma pneumoniae, Dtsch. Med. Wochenschr. 91:429–433 (1966).CrossRefGoogle Scholar
  175. 175.
    Wright, D. N., and Bailey, G. D., Effect of relative humidity on the stability of Mycoplasma pneumoniae exposed to simulated solar ultraviolet and to visible radiation, Can. J. Microbiol. 15:1449–1452 (1969).PubMedCrossRefGoogle Scholar
  176. 176.
    Yayoshi, M., Araake, M., Hayatsu, E., Kawakubo, Y., and Yoshioka, M., Characterization and pathogenicity of hemolysis mutants of Mycoplasma pneumoniae, Microbiol. Immunol. 28:303–310 (1984).PubMedGoogle Scholar

Suggested Reading

  1. Cassell, G. H., and Cole, B. C., Mycoplasmas as agents of human disease, N. Engl. J. Med. 304:80–89 (1981).PubMedCrossRefGoogle Scholar
  2. Clyde, W. A., Jr., Mycoplasma pneumoniae infections of man, in: The Mycoplasmas, Volume 2 (M. F. Barile and S. Razin, eds.), pp. 275–306, Academic Press, New York, 1979.CrossRefGoogle Scholar
  3. Current Insights in Mycoplasmology (O. Kitamoto, W. A. Clyde, Jr., H. Kobayashi, and M. F. Barile, guest eds.), Yale J. Biol. Med. 56:351–938 (1983).Google Scholar
  4. Denny, F. W., Clyde, W. A., Jr., and Glezen, W. P., Mycoplasma pneumoniae disease: Clinical spectrum, pathophysiology, epidemiology, and control, J. Infect. Dis. 123:74–92 (1971).PubMedCrossRefGoogle Scholar
  5. Foy, H. M., Pneumonia: Mycoplasma pneumoniae, in: Communicable and Infectious Diseases, 8th ed. (F. H. Top, Sr., and P. F. Wehrle, eds.), pp. 535–549, Mosby, St. Louis, 1976.Google Scholar
  6. Kenny, G. E., Antigenic determinants, in: The Mycoplasmas, Volume 1 (M. F. Barile and S. Razin, eds.), pp. 351–384, Academic Press, New York, 1979.CrossRefGoogle Scholar
  7. Levine, D. P., and Lerner, A. M., The clinical spectrum of Mycoplasma pneumoniae infections, Med. Clin. North Am. 62:961–978 (1978).PubMedGoogle Scholar
  8. PönkÄ, A., The occurrence and clinical picture of serologically verified Mycoplasma pneumoniae infections with emphasis on central nervous system, cardiac and joint manifestations, Ann. Clin. Res. 11(Suppl. 24):1–60 (1979).Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Hjordis M. Foy
    • 1
  1. 1.Department of Epidemiology, School of Public Health and Community MedicineUniversity of WashingtonWashingtonUSA

Personalised recommendations